TLR3 and bacterial infectious disease: Further research on the TLR3 signaling could offer interesting possibilities for AD drug-development programs, since TLR3 is considered an essential component of various defensive responses against viral and bacterial infections and its activation induces inflammatory damage to the CNS (Li et al., 2021).